Effaclar Duo Dual Action Acne Treatment
La Roche-Posay
Product Verdict Card
La Roche-Posay
Effaclar Duo Dual Action Acne Treatment
treatment
Consumer product research based on available product data, ingredients, pricing, and AI analysis. Not skin guidance.
Glow Score
Review tradeoffs first
Formula
Formula read is mixed; compare value before reading the score as a simple yes/no.
Fit flags
Fit is the main watch item; review the ingredient list and compare similar treatment options.
Value
Value is a caution flag; the score needs to justify the $34 price.
Compare this against other treatment products before buying — especially if price, texture, or ingredient fit matters for you.
Glow Index summary
AI skincare analysis for La Roche-Posay Effaclar Duo Dual Action Acne Treatment
Glow Index analyzed La Roche-Posay Effaclar Duo Dual Action Acne Treatment as a treatment using a 4-model AI skincare research process. It currently scores 59/100, with the strongest signals coming from ingredient efficacy, safety profile, value for money.
Use this page as a product research snapshot: compare the formula/value signals, read the model reasoning, then review the broader treatment rankings before deciding whether the product fits your preferences and budget.
Glow Index is a consumer research tool, not medical advice. Scores are based on product information and AI analysis of ingredients, pricing, evidence, and marketing claims. Patch test new products and consult a qualified professional for skin conditions or medical concerns.
Skip It
Our AI panel found this product underdelivers for the price.
Quick Take
Skip it. Better options exist.
Pros
- 5.5% micronized benzoyl peroxide is a clinically proven acne-fighting active, and the micronized format offers genuine pore-penetration advantages over standard BPO formulations.
- Capryloyl salicylic acid (LHA) adds meaningful pore-clearing and exfoliating benefits not found in cheaper single-active BPO alternatives, partially justifying the price premium.
- The fragrance-free formulation with glycerin and vitamin E humectants reduces sensitization risk and partially offsets BPO's drying effects — appropriate choices for acne-prone skin.
- 5.5 % micronized benzoyl peroxide plus LHA provides rapid antibacterial action and pore exfoliation
Cons
- All US lots were voluntarily recalled in early 2025 after confirmed benzene contamination — benzene is a Group 1 human carcinogen and this is a documented, not theoretical, safety failure.
- Silent reformulations across markets mean consumers cannot reliably know which active ingredient profile they are purchasing; the EU and US versions have fundamentally different actives under the same product name.
- At $34, the brand premium is difficult to justify when Paula's Choice CLEAR 5% BPO (~$21–33) and PanOxyl 4% BPO cream (~$11) deliver comparable or superior acne clearance with better formula stability histories.
- Past benzene contamination recall—buy fresh post-2025 lots only
Budget Alternative
Paula's Choice CLEAR Extra Strength Daily Skin Clearing Treatment 5% BPO — $21
Score Breakdown
How Each AI Scored
AI Consensus
11.00-pt disagreement4 AI models independently scored this product, then cross-checked each other’s reasoning. Tap a model to see its take.
FAQ
What does Glow Index measure for La Roche-Posay Effaclar Duo Dual Action Acne Treatment?
Glow Index evaluates non-medical skincare research signals: ingredient efficacy, safety profile, value for money, formula transparency, skin compatibility, and sensory usability.
Is this a medical recommendation?
No. Glow Index is not medical advice, not a diagnosis, and not a treatment recommendation. It is a consumer research layer for comparing skincare products and marketing claims.
Why does Glow Index use multiple AI models?
Multiple models reduce single-model bias. Glow Index surfaces consensus and disagreement instead of relying on one AI answer or brand marketing copy.